Literature DB >> 22508257

Therapeutic lifestyle changes for cardiovascular disease.

Randell Wexler1, Adam Pleister, Subha V Raman, James R Borchers.   

Abstract

Cardiovascular disease, including hypertension, coronary artery disease, and heart failure, is common in the general US population. The mainstay of treatment for this cohort is implementing therapeutic lifestyle changes (TLCs). Therapeutic lifestyle changes include a reduced-sodium diet, the Dietary Approaches to Stop Hypertension (DASH) diet, weight loss, moderation of alcohol consumption, and increased aerobic exercise. It is important to emphasize that exercise should be recommended to all patients, even for those who historically were told not do so, such as those with heart failure. When prescribing harmacotherapy, physical activity should be taken into account. Athletes competing at the top level warrant adherence to the restrictions of the World Anti-Doping Agency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508257     DOI: 10.3810/psm.2012.02.1957

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  3 in total

1.  Exercise, load and remodelling: do we know what we think we know?

Authors:  Michael Ibrahim; James E Cartledge
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

2.  No short-term effects of calorie-controlled Mediterranean or fast food dietary interventions on established biomarkers of vascular or metabolic risk in healthy individuals.

Authors:  Marijo Parcina; Maik Brune; Vareska Kaese; Markus Zorn; Rainer Spiegel; Valerija Vojvoda; Thomas Fleming; Gottfried Rudofsky; Peter Paul Nawroth
Journal:  Nutr Res Pract       Date:  2014-12-10       Impact factor: 1.926

3.  Intra-operative grading of coronary artery atherosclerosis associated with homocysteine levels in postmenopausal women undergoing elective off-pump CABG surgery.

Authors:  Seyed Jalil Mirhosseini; Seyed Khalil Forouzannia; Seyed Ali Mirhosseini; Sadegh Ali-Hassan-Sayegh; Mohammad Reza Mozayan
Journal:  Niger Med J       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.